"HeLa Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays.
| Descriptor ID |
D006367
|
| MeSH Number(s) |
A11.251.210.190.400 A11.251.860.180.400 A11.436.340
|
| Concept/Terms |
HeLa Cells- HeLa Cells
- Cell, HeLa
- Cells, HeLa
- HeLa Cell
|
Below are MeSH descriptors whose meaning is more general than "HeLa Cells".
Below are MeSH descriptors whose meaning is more specific than "HeLa Cells".
This graph shows the total number of publications written about "HeLa Cells" by people in this website by year, and whether "HeLa Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 3 | 3 |
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 3 | 3 |
| 1997 | 0 | 5 | 5 |
| 1998 | 0 | 5 | 5 |
| 1999 | 0 | 3 | 3 |
| 2000 | 0 | 7 | 7 |
| 2001 | 0 | 7 | 7 |
| 2002 | 0 | 13 | 13 |
| 2003 | 0 | 17 | 17 |
| 2004 | 0 | 23 | 23 |
| 2005 | 0 | 16 | 16 |
| 2006 | 0 | 15 | 15 |
| 2007 | 0 | 14 | 14 |
| 2008 | 0 | 20 | 20 |
| 2009 | 0 | 22 | 22 |
| 2010 | 0 | 19 | 19 |
| 2011 | 0 | 24 | 24 |
| 2012 | 0 | 19 | 19 |
| 2013 | 0 | 16 | 16 |
| 2014 | 0 | 21 | 21 |
| 2015 | 0 | 14 | 14 |
| 2016 | 0 | 11 | 11 |
| 2017 | 0 | 17 | 17 |
| 2018 | 0 | 8 | 8 |
| 2019 | 0 | 13 | 13 |
| 2020 | 0 | 10 | 10 |
| 2021 | 0 | 6 | 6 |
| 2022 | 0 | 4 | 4 |
| 2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "HeLa Cells" by people in Profiles.
-
Nm-Mut-seq: a base-resolution quantitative method for mapping transcriptome-wide 2'-O-methylation. Cell Res. 2023 09; 33(9):727-730.
-
Methyltransferase Inhibition Enables Tgfß Driven Induction of CDKN2A and B in Cancer Cells. Mol Cell Biol. 2023; 43(3):115-129.
-
Identification of Clostridium innocuum hypothetical protein that is cross-reactive with C. difficile anti-toxin antibodies. Anaerobe. 2022 Jun; 75:102555.
-
CASowary: CRISPR-Cas13 guide RNA predictor for transcript depletion. BMC Genomics. 2022 Mar 02; 23(1):172.
-
Cataract-linked serine mutations in the gap junction protein connexin50 expose a sorting signal that promotes its lysosomal degradation. J Biol Chem. 2022 03; 298(3):101673.
-
Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2. Nat Commun. 2022 01 20; 13(1):405.
-
Constitutive, Basal, and ß-Alanine-Mediated Activation of the Human Mas-Related G Protein-Coupled Receptor D Induces Release of the Inflammatory Cytokine IL-6 and Is Dependent on NF-?B Signaling. Int J Mol Sci. 2021 Dec 09; 22(24).
-
Methylglyoxal Forms Diverse Mercaptomethylimidazole Crosslinks with Thiol and Guanidine Pairs in Endogenous Metabolites and Proteins. ACS Chem Biol. 2021 11 19; 16(11):2453-2461.
-
ALKBH7-mediated demethylation regulates mitochondrial polycistronic RNA processing. Nat Cell Biol. 2021 07; 23(7):684-691.
-
Cancer-causing BRCA2 missense mutations disrupt an intracellular protein assembly mechanism to disable genome maintenance. Nucleic Acids Res. 2021 06 04; 49(10):5588-5604.